# Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma

> **NCT00817258** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 37 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** cisplatin
- **RADIATION:** 3D-CRT (three-dimensional conformal radiation therapy) or IMRT (intensity-modulated radiation therapy)

## Key facts

- **NCT ID:** NCT00817258
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-12
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2009-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00817258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00817258, "Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00817258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*